Published in Hepatitis Weekly, January 10th, 2000
A conference on the newest advances by the pharmaceutical industry in developing novel drugs to fight viral diseases, including respiratory/influenza, HIV, and hepatitis B and C, will follow on March 15-16.
The international conference will feature promising antibacterial clinical agents including oxazolidinones, glycylcyclines, beta-lactamases, carbapenems, quinolones, ketolides,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.